This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪、
粘弹剂、药物缓释系统载体、抗纤维增生药物等的应
进行
要的介绍。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪、
粘弹剂、药物缓释系统载体、抗纤维增生药物等的应
进行
要的介绍。
声明:以上例句、词性类均由互联网资源自动生
,
未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
文就壳聚糖作为人工
液、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行
要的介绍。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其达内容亦不代
软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医用粘弹剂、药物统载体、抗纤维增生药物等的应用进行
要的介绍。
声明:以上例句、词性分类均由资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行要的介绍。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的;
发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文糖作为人工泪液、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行
要的介绍。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审,
达内容亦不代
本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医用粘弹、
缓释系统载体、抗纤维增生
等的应用进行
要的介绍。
声明:以上例句、词性分类均由互联网动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚泪液、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行
要的介绍。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作为人工泪液、医粘弹剂、药物缓释系统载体、抗纤维增生药物等
应
绍。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件观点;若发现问题,欢迎向我们指正。
This article reviewed the therapeutic use of chitosan as artificial lacrima, medical viscoelastic material, carrier of drug delivery systems and so on in ophthalmic disease.
本文就壳聚糖作泪液、医用粘弹剂、药物缓释系统载体、抗纤维增生药物等的应用进行
要的介绍。
声明:以上例句、词性分类均由互联网资源自动生成,部分未审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。